It was revealed that a drug used to treat diabetes slows down the progression of motor nerve problems caused by Parkinson’s disease.
Affecting 10 million people worldwide Parkinson’s There is no treatment yet for the disease. In this brutal nervous system disorder, people cannot stop their hands and limbs from shaking rhythmically, their movements slow down, they have difficulty speaking and cannot maintain their balance. These symptoms get worse as time goes by.
Researchers have discovered a drug that mimics a gut hormone, often used to treat diabetes. GLP-1 receptor agonist When they wanted to test whether it could protect neurons, they came across an interesting result. There were no significant results in previous studies. A new research gives hope to Parkinson’s patients.
Tested with 156 people
With the participation of 156 patients in the new research GLP-1The effect of was tested. Patients were randomly assigned to lixisenatide or placebo medication was given. It was revealed that there was no improvement in movement-related symptoms of patients given lixisenatide, whose condition was followed for a year. According to researchers, this effect intermediate happened and could only be observed when checked by experts.
According to the researchers, this study is an important start, but there is still work to be done. more clinical trials It needs to be done. After further safety review, this drug can be used to treat patients. The authors of the study state that they are eagerly awaiting the results of similar studies by other scientists.
Research New England Journal of MedicineIt was published in .
RELATED NEWS
From Health to Communication: US Inventions That Radically Changed Humanity’s Life When You Read It Will Make You Question “Did They Do That Too?”
RELATED NEWS
Diseases such as Parkinson’s and Alzheimer’s can be prevented thanks to a new device developed with the support of artificial intelligence
Source :
https://www.sciencealert.com/this-is-the-first-time-drug-shows-signs-of-slowing-parkinsons-disease
$(function(){
//facebook window.fbAsyncInit = function() { FB.init({ appId : '1037724072951294', xfbml : true, version : 'v2.5' }); };
(function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/tr_TR/sdk.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));
$('body').on({ click: function() { // facebook save button ajax FB.XFBML.parse(); } }, '.facebook-save');
// share scroll if ($('.content-sticky').length > 0) { if ($(window).width() >= 768) { $(window).on('scroll', function () { var scrollTop = $(this).scrollTop(); $('article').each(function () { if (scrollTop >= ($(this).find('.content-body').offset().top - 76)) { $(this).find('.content-sticky').addClass('sticky'); if (scrollTop >= ($(this).find('.content-body').offset().top + $(this).find('.content-body').height() - ($(this).find('.content-sticky').height() + 92))) { $(this).find('.content-sticky').removeClass('sticky'); $(this).find('.content-sticky').css({'bottom': '0px', 'top': 'auto'}); } else { $(this).find('.content-sticky').addClass('sticky').css({ 'bottom': 'initial', 'top': '76px' }); } } else { $(this).find('.content-sticky').removeClass('sticky').css({'bottom': 'auto', 'top': '0'}); } }); }); } }
// share click $('body').on({ click: function (){ var $this = $(this), dataShareType = $this.attr('data-share-type'), dataType = $this.attr('data-type'), dataId = $this.attr('data-id'), dataPostUrl = $this.attr('data-post-url'), dataTitle = $this.attr('data-title'), dataSef = $this.attr('data-sef');
switch(dataShareType) { case 'facebook': FB.ui({ method: 'share', href: dataSef, }, function(response){ if (response && !response.error_message) { updateHit(); } });
break;
case 'twitter': shareWindow('https://twitter.com/intent/tweet?via=webtekno&text="+encodeURIComponent(dataTitle) + " %E2%96%B6 ' + encodeURIComponent(dataSef)); updateHit(); break;
case 'gplus': shareWindow('https://plus.google.com/share?url=" + encodeURIComponent(dataSef)); updateHit(); break;
case "mail': window.location.href="https://www.webtekno.com/mailto:?subject=" + encodeURIComponent(dataTitle) +'&body='+ encodeURIComponent(dataSef); //updateHit(); break;
case 'whatsapp': window.location.href="whatsapp://send?text=" + encodeURIComponent(dataTitle) +' %E2%96%B6 '+ encodeURIComponent(dataSef); updateHit(); break; }
function shareWindow (url) { window.open(url, "_blank", "toolbar=yes, scrollbars=yes, resizable=yes, top=500, left=500, width=400, height=400"); }
function updateHit () { $.ajax({ type: "POST", url: dataPostUrl, data: {contentId: dataId, contentType: dataType, shareType: dataShareType}, success: function(data) {
if ($('.video-showcase').length > 0) { var $container = $('.video-showcase'); } else if ($('article[data-id="' + dataId + '"]').length > 0) { var $container = $('article[data-id="' + dataId + '"]'); } else if ($('.wt-share-item[data-id="' + dataId + '"]').length > 0) { var $container = $('.wt-share-item[data-id="' + dataId + '"]'); } else { $container = null; }
//var $container = dataType == 'video' ? $('.video-showcase') : $('article[data-id="' + dataId + '"]');
if ( $container != null && $container.length > 0 ) { var $badged = $container.find('.wt-share-badge-' + dataShareType);
var $headerCount = $('.content-header').find('.wt-share-count'), $containerCount = $container.find('.wt-share-count'), value = parseInt($containerCount.html()) + 1;
$container.data('share', value); //$containerCount.html(value);
if ($headerCount.length > 0) { //$headerCount.html(value); }
if ( $badged.length > 0 && (dataShareType == 'facebook' || dataShareType == 'twitter')) { if ($badged.hasClass('is-visible')) { //$badged.html(data); } else { //$badged.addClass('is-visible').html(data); } } }
} }); } } }, '.wt-share-button') });